A Trial to Assess the Effect of High Nitrogen Intake in Critically Ill Patients
The Efficacy and Safety of High Nitrogen Intake in Critically Ill Patients: a Randomized and Controlled Trial
1 other identifier
interventional
89
1 country
1
Brief Summary
The patients with sepsis are in high risk of malnutrition, which could contribute to infection, difficulty in weaning from ventilators. The investigators speculate whether nutrition therapy with high nitrogen could attenuate the malnutrition status and improve the outcome in these sepsis patients. In this prospective Randomized Controlled Trial, the investigators aim to compare high nitrogen intake with conventional nitrogen supply which were recommended in guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2014
CompletedFirst Posted
Study publicly available on registry
April 8, 2014
CompletedStudy Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedMay 27, 2020
May 1, 2020
4.8 years
March 30, 2014
May 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
all cause mortality
28 days
all cause mortality
90 days
Secondary Outcomes (7)
duration on ventilators
patients enrolled will be followed for the duration of mechanical ventilation, an expcected average of 4 weeks
ICU stay
patients enrolled will be followed for length of ICU stay, an expected average of 6 weeks
infection incidence rate
28 days
Liver function and renal function
on 1st. day, 3rd. day, 7th. day, 14th. day, 21st. day, 28th. day after enrollment
diameter of midpoint of musculus rectus femoris
on 28th. day or endpoint of the trial
- +2 more secondary outcomes
Study Arms (2)
High Nitrogen
EXPERIMENTALIn this arm, daily nitrogen supply is as much as 2.5-3.0 g per kilogram (lean mass weight)
conventional nitrogen
ACTIVE COMPARATORIn this arm, daily nitrogen supply is 1.2-1.5g per kilogram (lean mass weight) as recommended by ESPEN guideline
Interventions
Nitrogen supply could be administered through amino acid in parenteral nutrition, proteins in enteral nutrition.
Eligibility Criteria
You may qualify if:
- need mechanical ventilation for more than 2 days
- mean blood pressure more than 60mmHg
- predicted ICU stay more than 7 days
- tolerance of parenteral or enteral nutrition
You may not qualify if:
- irreversible status of primary disease
- any history of malnutrition before enrollment
- history of steroid cortisol administration
- severe liver dysfunction (Child-Pugh Score C)
- pregnancy
- refuse to enrollment
- re-admission to ICU and has been enrolled during former admission to ICU
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Critical Care Medicine: Zhongshan Hospital
Shanghai, Shanghai Municipality, 200032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Division of Critical Care Medicine
Study Record Dates
First Submitted
March 30, 2014
First Posted
April 8, 2014
Study Start
March 1, 2015
Primary Completion
January 1, 2020
Study Completion
May 1, 2020
Last Updated
May 27, 2020
Record last verified: 2020-05